Phase
Condition
Heart Defect
Heart Disease
Low Blood Pressure (Hypotension)
Treatment
Single-Chamber Transvenous Pacemaker
Aveir VR Leadless Pacemaker System
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
The study cohort will include all Medicare patients with continuous claims data implanted with an Aveir VR leadless pacemaker or a full-system single-chamber ventricular transvenous pacemaker (from any manufacturer) in any US location
Inclusion Criteria:
Medicare beneficiaries implanted with an Aveir VR leadless pacemaker on or after the study start date (i.e., the date of Aveir VR market approval) will be included in the study.
OR
Medicare beneficiaries implanted with a full system (e.g. lead and generator) single-chamber ventricular transvenous pacemaker on or after the study start date
Exclusion
Exclusion Criteria:
None
Study Design
Study Description
Connect with a study center
Abbott
Sylmar, California 91342
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.